PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'INSERM UMR-S 935 and University Paris Saclay, Villejuif, France.\', \'INGESTEM National IPSC Infrastructure, Villejuif, France.\', \'Gustave Roussy Institute, Villejuif and Faculty of Pharmacy, Paris Descartes University, Paris, France.\', \'APHP Paris Saclay Division of Hematology and University Paris Saclay Faculty of Medicine, Villejuif, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/sctm.20-0189
?:hasPublicationType
?:journal
  • Stem cells translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 33237619
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.722
?:rankingScore_hIndex
  • 45
is ?:relation_isRelatedTo_publication of
?:title
  • Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID-19-associated organ failure.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all